Targeted Therapies in Advanced Renal Cell Cancer
نویسندگان
چکیده
منابع مشابه
Progress of Molecular Targeted Therapies for Advanced Renal Cell Carcinoma
Vascular endothelial growth factor (VEGF) plays a crucial role in tumor angiogenesis. VEGF expression in metastatic renal cell carcinoma (mRCC) is mostly regulated by hypoxia, predominantly via the hypoxia-induced factor (HIF)/Von Hippel-Lindau (VHL) pathway. Advances in our knowledge of VEGF role in tumor angiogenesis, growth, and progression have permitted development of new approaches for th...
متن کاملEmerging efficacy endpoints for targeted therapies in advanced renal cell carcinoma.
Several novel targeted agents are being tested for the treatment of advanced renal cell carcinoma (RCC), and results of phase I and II trials have been encouraging. A recently completed phase III, placebo-controlled study showed that median progression-free survival doubled from 12 weeks to 24 weeks in patients treated with the multi-kinase inhibitor sorafenib (Nexavar) (hazard ratio [HR], 0.44...
متن کاملTargeted therapies and survival: what we can learn from studies in advanced renal cell carcinoma.
subgroups of patients bearing such abnormalities, in this way achieving substantial survival improvements as it appears from the undeniable results obtained in HER2+ advanced breast cancer patients or in KRAS+ non-small cell lung cancer patients [1] . Similar and maybe even more important considerations can be made concerning advanced/metastatic renal cell carcinoma (m-RCC). Following the explo...
متن کاملRationale for targeted therapies and potential role of pazopanib in advanced renal cell carcinoma
Advanced renal cell carcinoma (RCC) remains a challenging, major health problem. Recent advances in understanding the fundamental biology underlying one form of RCC, ie, clear cell (or conventional) RCC, have opened the door to a series of targeted agents, such as the tyrosine kinase inhibitors (TKIs), which have become the standard of care in managing advanced clear cell RCC. Among the newest ...
متن کاملTargeted Therapies in Breast Cancer: Implications for Advanced Oncology Practice
The systemic therapeutic management of breast cancer has undergone significant transformation in the past decade. Without targeted therapies, conventional treatment with cytotoxic agents has reached the limit of its potential in terms of patient survival for most types of cancer. Enhanced understanding of the pathogenesis of tumor cell growth and metastasis has led to the identification of sign...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Üroonkoloji Bülteni
سال: 2015
ISSN: 2147-2270
DOI: 10.4274/uob.396